Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 687

1.

Effect of catalpol on diabetic nephropathy in rats.

Dong Z, Chen CX.

Phytomedicine. 2013 Aug 15;20(11):1023-9. doi: 10.1016/j.phymed.2013.04.007. Epub 2013 Jun 5.

PMID:
23746755
2.

[Protective effects of Salvia miltiorrhiza on rats with streptozotocin diabetes and its mechanism].

Liu G, Guan GJ, Qi TG, Fu YQ, Li XG, Sun Y, Wu T, Wen RZ.

Zhong Xi Yi Jie He Xue Bao. 2005 Nov;3(6):459-62. Chinese.

3.
4.

[Protective effects and mechanisms of xin'ganbao capsule on STZ induced early kidney injury in diabetic rats].

Gao J, Fan L, Liu MJ.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Apr;32(4):530-6. Chinese.

PMID:
22803438
5.

Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c.

Wen X, Zeng Y, Liu L, Zhang H, Xu W, Li N, Jia X.

J Ethnopharmacol. 2012 Jun 26;142(1):144-50. doi: 10.1016/j.jep.2012.04.028. Epub 2012 May 4.

PMID:
22564814
6.
7.

Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.

Qi MY, Kai-Chen, Liu HR, Su YH, Yu SQ.

J Ethnopharmacol. 2011 Dec 8;138(3):731-6. doi: 10.1016/j.jep.2011.10.015. Epub 2011 Oct 19.

PMID:
22027446
8.

Kidney involvement in a nongenetic rat model of type 2 diabetes.

Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE.

Kidney Int. 2005 Dec;68(6):2562-71.

9.

[The effect of losartan on glomerular sclerosis in rats with diabetic nephropathy].

Xu JY, Tao LJ, Wang L, Ning WB, Liu JS.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Sep;33(9):836-40. Chinese.

10.
11.

[Renal protective effect of valsartan in diabetic rats].

Wen H, Lin S.

Zhonghua Nei Ke Za Zhi. 1999 Mar;38(3):157-60. Chinese.

PMID:
11798641
12.

Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.

Makino H, Mukoyama M, Sugawara A, Mori K, Suganami T, Yahata K, Fujinaga Y, Yokoi H, Tanaka I, Nakao K.

Clin Exp Nephrol. 2003 Mar;7(1):33-40.

PMID:
14586741
13.

Effects of vitamin D on renal fibrosis in diabetic nephropathy model rats.

Tian Y, Lv G, Yang Y, Zhang Y, Yu R, Zhu J, Xiao L, Zhu J.

Int J Clin Exp Pathol. 2014 May 15;7(6):3028-37. eCollection 2014.

14.

Effects of Ginkgo biloba on prevention of development of experimental diabetic nephropathy in rats.

Lu Q, Yin XX, Wang JY, Gao YY, Pan YM.

Acta Pharmacol Sin. 2007 Jun;28(6):818-28.

15.

Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.

Mao ZM, Shen SM, Wan YG, Sun W, Chen HL, Huang MM, Yang JJ, Wu W, Tang HT, Tang RM.

J Ethnopharmacol. 2015 Sep 15;173:256-65. doi: 10.1016/j.jep.2015.07.036. Epub 2015 Jul 28.

PMID:
26226437
16.
17.

Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats.

Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, Veeraveedu PT, Arozal W, Sukumaran V, Lakshmanan AP, Arumugam S, Suzuki K.

Mol Nutr Food Res. 2011 Nov;55(11):1655-65. doi: 10.1002/mnfr.201100080. Epub 2011 Aug 30.

PMID:
22045654
18.

Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.

Wang JJ, Zhang SX, Mott R, Knapp RR, Cao W, Lau K, Ma JX.

Diabetes. 2006 Jun;55(6):1678-85.

19.

Effect of astilbin on experimental diabetic nephropathy in vivo and in vitro.

Li GS, Jiang WL, Yue XD, Qu GW, Tian JW, Wu J, Fu FH.

Planta Med. 2009 Nov;75(14):1470-5. doi: 10.1055/s-0029-1185802. Epub 2009 Jun 16.

PMID:
19644810

Supplemental Content

Support Center